List of works - Carlo Fabris

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

scientific article published on June 2008

Antiviral treatment of hepatitis C.

scientific article published on October 2006

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated

scientific article

Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment.

scientific article published on September 2004

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort

scientific article

Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.

scientific article published on 12 May 2009

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

scientific article

Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

scientific article published on October 2005

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C

scientific article

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

scientific article published on 27 May 2013

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

scientific article published on 4 February 2009

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

scientific article published on April 2009

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis

scientific article published on 28 September 2015

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus

scientific article published on October 2008

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

scientific article published on 7 June 2011

Updates on antiviral therapy for chronic hepatitis C.

scientific article published on February 2007

Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.

scientific article published on February 2007

Vitamin D and the risk of acute allograft rejection following human liver transplantation.

scientific article published on 22 October 2009

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

scientific article published on 14 October 2012

Vitamin D deficiency and HCV chronic infection: what comes first?

scientific article published on 22 February 2011

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis

scientific article

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

scientific article

List of works by Carlo Fabris

Antiviral treatment in patients with hepatitis C virus-related cirrhosis awaiting liver transplantation

Antiviral treatment of hepatitis C.

Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated

Carriage of the apolipoprotein E-epsilon4 allele and histologic outcome of recurrent hepatitis C after antiviral treatment.

Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort

Combinatorial use of single nucleotide polymorphisms to help predict liver fibrosis in patients with hepatitis C infections.

Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.

Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation

Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

Occult hepatitis B virus infection in liver transplant recipients with recurrent hepatitis C: relationship with donor age and fibrosis progression

Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia

PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis

R-1626, a specific oral NS5B polymerase inhibitor of hepatitis C virus

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

Updates on antiviral therapy for chronic hepatitis C.

Valopicitabine dihydrochloride:a specific polymerase inhibitor of hepatitis C virus.

Vitamin D and the risk of acute allograft rejection following human liver transplantation.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C.

Vitamin D deficiency and HCV chronic infection: what comes first?

Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.